YITYY yields 6.02% · JNJ yields 2.13%● Live data
📍 JNJ pulled ahead of the other in Year 6
Combined, YITYY + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of YITYY + JNJ for your $10,000?
YIT Oyj provides construction services for industrial and public sectors, and residential customers primarily in Finland, Sweden, Norway, Russia, the Czech Republic, Slovakia, Poland, Baltic countries, and internationally. The company operates through five segments: Housing Finland and CEE, Housing Russia, Business Premises, Infrastructure, and Partnership Properties. It develops and builds apartments and residential areas, as well as provides real estate property management, maintenance, and living services; develops wind power plants; and constructs office, commercial, business, logistics and industrial, and public buildings, such as hospitals, schools, and multi-purpose buildings. The company also undertakes pipe renovation works for housing companies; builds roads, bridges, railway and metro stations, and ports and parking facilities, as well as energy, water supply, and industrial plants; maintains roads, streets, and green areas; and offers tunnel quarrying, mining, and reinforcement services. In addition, it provides property development services. The company was founded in 1912 and is headquartered in Helsinki, Finland.
Full YITYY Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.